Navigation Links
FDA to Review Clotting Drug After Trial Suggests Death Risk
Date:10/25/2007

Findings come as another blow to Trasylol, used to cut down on bleeding during cardiac surgery

THURSDAY, Oct. 25 (HealthDay News) -- The U.S. Food and Drug Administration on Thursday said it will review the safety of the clotting drug aprotinin (Trasylol), after a major Canadian trial was stopped early due to an increase in deaths for cardiac surgery patients placed on the drug.

Trasylol, first approved by the FDA in 1993, is typically used to limit blood loss in patients undergoing cardiac surgery.

While less bleeding was noted in the aprotinin group versus patients assigned one of two other drugs, "a trend toward increased mortality in the aprotinin group had been observed throughout the study," the FDA noted in a statement released Thursday.

That elevated 30-day and overall death risk caused the Canadian study's Data Safety Monitoring Board (DSMB) to recommend stopping patient enrollment in the so-called BART trial. The trial was set to recruit about 3,000 adults who were candidates for a variety of cardiac surgeries and were at high risk of bleeding.

"The DSMB concluded that continued enrollment of patients into the aprotinin group was unlikely to significantly change the study findings," the FDA said.

Trasylol's maker, Bayer, also issued a new "guidance" to doctors on Thursday. The German company advises "that physicians use Trasylol only in accordance with approved product labeling." Bayer said it believes the drug "remains a safe and effective treatment option for physicians," but it is working with the FDA and international health authorities to see if any label changes might become necessary as new data emerges.

Trasylol has had a checkered history since it was first approved by the FDA in 1993.

On Sept. 12, a U.S. Food and Drug Administration advisory panel recommended that aprotinin remain on the market, despite evidence that it might have serious side effects.'/>"/>

Copyright©2007 ScoutNews,LLC.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. FDA may speed review of new drugs
2. Scientists review SARS
3. US Reviews Risks Of Tamiflu After 12 Children Die
4. Breast Cancer Examinations To Be Reviewed In Irish Hospitals
5. BioCryst’s Bird Flu Drug Enjoys Fast-Track Review By FD
6. A Sneak Preview of Human’s Susceptibility to Auto Immune Disease, Allergy, Asthm
7. Thumbs up in weight loss for vegetarian diets: scientific review
8. FDA Accords Priority Review For Pediatric Crohns Disease Drug
9. The Lancet Calls For Review Of Regulatory Process Of Drug Trials
10. Review of Pramod Mahajans Injuries
11. Vaticans Council Reviews Condom Usage
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... May 24, 2013 This week is ... and their efforts to provide the best emergency care ... of this week is also to educate the public ... of survival. Citizens are the first link, and a ... proper bystander CPR after a cardiac arrest can triple ...
(Date:5/24/2013)... Bethany Beach, Delaware (PRWEB) May 24, 2013 ... Tammy Mushrush has joined the Dayna Feher team at ... Pa., Mushrush made the Delaware resorts her home in ... she has since worked in all aspects of the ... operations, and for the past 12 years, a licensed ...
(Date:5/24/2013)... 24, 2013 E-Dentists.com has announced the ... with JD Media Surge, a leading medical Internet marketing ... SEO analysis service will focus on providing dentists the ... engines for their competitive keywords. The dental SEO analysis ... recommendations based on what their competitors are doing right. ...
(Date:5/24/2013)... Let’s face it: very few are luckily ... the majority of people to be uncomfortable with the color ... coffee addiction or simply genetics, yellowish or stained teeth suppresses ... , Herald Square Dental is proud to announce ... Venus White Max. , Teeth become discolored for a ...
(Date:5/24/2013)... May 24, 2013 Mr. Brian Su, ... 3rd Annual EB-5 Investment Summit: Dealmakers Conference in Long ... will focus on exploring alternative finance through EB-5 immigrant ... legal and economic information, and updates to project developers, ... EB-5 industry. , "Our goal is to assist ...
Breaking Medicine News(10 mins):Health News:Acadian Medics Reunite with Miracle Baby 2Health News:Tammy Mushrush Joins ResortQuest Real Estate® and the Dayna Feher Team 2Health News:Dental SEO Analysis Launched by E-Dentists.com in Partnership with JD Media Surge 2Health News:Herald Square Dental Introduces New In-office Whitening System: Venus White Max 2Health News:Brian Su Organizes 3rd Annual EB-5 Investment Conference in Long Beach, California 2
... ... ... contributions of voluntary plasma donors and the issue of treating critically ill ... proclaimed August "Plasma Protein Therapies Month" in the Lone Star State. , , ,"Patients ...
... ... on top of current events in the health care industry. , ... Seattle, Washington (PRWEB) August 19, 2009 -- Today, All Allied Health Schools ... helps students keep up with the latest developments in the health care industry--and how these changes ...
... , ANN ARBOR, Mich., Aug. 19 The median profit ... of 2008 to 3.1 percent in the first quarter of 2009, according ... , The recovery has been broad-based, with all classes ... major teaching hospitals -- showing positive median margins. , ...
... ... the Causes of this Growing Trend , ... Jacksonville, Fla. (Vocus) August 18, 2009 -- A recent National Institute of Health ... the growing popularity of alternative therapies for both healthcare treatment and prevention. ...
... A nearly two-decade trend that is stripping away employer-provided ... continue and could soon hit an even deeper pool ... Illinois elder law expert warns. Richard L. Kaplan ... largely from a 1992 change in accounting standards that ...
... , NEW YORK, NY, Aug. 18 /PRNewswire-FirstCall/ - (OTCBB: ... that identifies, acquires, and develops novel drug targets that ... Whiteman as its Chief Executive Officer. , Mr. Whiteman, ... London School of Economics . He will provide ...
Cached Medicine News:Health News:Plasma protein Therapies Association Focuses Attention on Donors and Facilities 2Health News:Plasma protein Therapies Association Focuses Attention on Donors and Facilities 3Health News:All Allied Health Schools Launches "Health Care Community" 2Health News:All Allied Health Schools Launches "Health Care Community" 3Health News:Thomson Reuters Study Finds Impact of Recession Easing on U.S. Hospitals 2Health News:Thomson Reuters Study Finds Impact of Recession Easing on U.S. Hospitals 3Health News:Alternative Therapies And Their Growing Popularity 2Health News:Alternative Therapies And Their Growing Popularity 3Health News:Alternative Therapies And Their Growing Popularity 4Health News:Retirees' health-care benefits at risk, study warns 2Health News:Retirees' health-care benefits at risk, study warns 3Health News:GENova names Aaron Whiteman as CEO 2Health News:GENova names Aaron Whiteman as CEO 3
(Date:5/24/2013)... , May 24, 2013 ... administration for systemic delivery of therapeutic agents has been ... inhalation drug delivery showing significant promise. The crucial formulation ... a delivery device play a major role in the ... made in the development of new formulation techniques and ...
(Date:5/23/2013)... SAN DIEGO , May 23, 2013 Neurocrine ... Kevin Gorman , President and Chief Executive ... Bank 38 th Annual dbAccess Health Care Conference in ... Thursday, May 30 at 11:20 a.m. Eastern Time / 8:20 ... be accessed on the Company,s website at http://www.neurocrine.com . ...
(Date:5/23/2013)... Minn. , May 23, 2013  MGC Diagnostics ... a global medical technology company, today scheduled a conference ... quarter of fiscal year 2013, ended April 30, 2013. ... Thursday, May 30, 2013. The Company will report financial ... after the markets close on Thursday, May 30, 2013. ...
Breaking Medicine Technology:Inhalaltion Drug Delivery: 11-12 September - Berlin, Germany 2MGC Diagnostics Corporation to Report Second Quarter Fiscal 2013 Financial Results on Thursday, May 30, 2013 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: